Skip to main content

Advertisement

SpringerLink
Log in

Neurofibromatosis Type 1 Gene Haploinsufficiency Reduces AP-1 Gene Expression without Abrogating the Anabolic Effect of Parathyroid Hormone

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Approximately 50% of neurofibromatosis type 1 (NF1) patients exhibit skeletal pathology, such as premature osteoporosis or pseudoarthroses. Loss of neurofibromin deregulates Ras signal transduction to affect generation of mitogen-activated protein kinase and Akt, both of which have been implicated in parathyroid hormone (PTH) anabolic mechanisms. Our aim was to determine if loss of neurofibromin impaired the anabolic effect of PTH on bone mass. Nf1 heterozygote (Nf1+/−) and wild type (Nf1+/+) mice were treated with recombinant human PTH1–34 or vehicle once daily for 3–28 days. PTH enhanced mRNA expression of c-fos, junB, and fra2 in the distal femur metaphyses of both genotypes; expression of these transcripts was consistently lower in PTH-treated Nf1+/− mice. Despite lowered c-fos expression in Nf1+/− mice, PTH increased bone mass equivalently in both genotypes by 28 days. Ex vivo, Nf1 heterozygosity was associated with increased inducible osteoclasts in PTH-treated bone marrow cells and impairment of the actin stress fiber and cyclic adenosine monophosphate response to PTH in osteoprogenitors. Lower c-fos expression was previously thought to abrogate PTH responsiveness. Our results suggest crosstalk might occur between Ras signal transduction and the protein kinase A pathway in Nf1+/− mice. Ras signal transduction does not appear to be essential for the anabolic actions of PTH on bone. Because PTH was effective in the absence of Nf1, it may offer a useful approach to treat osteoporosis in NF1 patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Riccardi V, Womack JE, Jacks T (1994) Neurofibromatosis and related tumors. Natural occurrence and animal models. Am J Pathol 145: 994–1000

    CAS  PubMed  Google Scholar 

  2. Crawford A, Schorry E (1999) Neurofibromatosis in children: the role of the orthopedist. J Am Acad Orthop Surg 7: 217–230

    CAS  PubMed  Google Scholar 

  3. Vitale M, Guha A, Skaggs D (2002) Orthopedic manifestations of neurofibromatosis in children: an update. Clin Orthop Relat Res 1: 107–118

    Google Scholar 

  4. Gilbert A, Brockman R (1995) Congenital pseudarthrosis of the tibia. Clin Orthop 314: 37–44

    PubMed  Google Scholar 

  5. Illes T, Halmai V, de Jonge T, Dubousset J (2001) Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 12: 823–827

    CAS  PubMed  Google Scholar 

  6. Kuorilehto T, Poyhonen M, Bloigu R, Heikkinen J, Vaananen K, Peltonen J (2005) Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int 16: 928–936

    Article  CAS  PubMed  Google Scholar 

  7. Yu X, Chen S, Potter OL, Murthy SM, Li J, Pulcini JM, Ohashi N, Winata T, Everett ET, Ingram D, Clapp WD, Hock JM (2005) Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36: 793–802

    CAS  PubMed  Google Scholar 

  8. Elefteriou F, Benson DM, Liu X, Parada L, Karsenty G (2005) Neurofibromin (Nf1) through its expression in osteoblasts, controls bone formation and bone resorption. J Bone Miner Res (suppl 1):S14

    Google Scholar 

  9. McCormick F (1995) Ras signaling and NF1. Curr Opin Genet Dev 5: 51–55

    Article  CAS  PubMed  Google Scholar 

  10. Hiatt KK, Ingram DA, Zhang Y, Bollag G, Clapp DW (2001) Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1−/− cells. J Biol Chem 276: 7240–7245

    Article  CAS  PubMed  Google Scholar 

  11. Zhu Y, Ghosh P, Charnay P, Burns D, Parada L (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296: 920–922

    CAS  PubMed  Google Scholar 

  12. Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiatt K, New S, Hood A, Shannon K, Williams DA, Clapp DW (2000) Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191: 181–188

    Article  CAS  PubMed  Google Scholar 

  13. Lindsay R, Nieves J, Formica C, Henneman C, Woelfert L, Shen V, Dempster D, Cosman F (1997) Randomised controlled study of effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350: 550–555

    Article  CAS  PubMed  Google Scholar 

  14. Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res 17: 2038–2047

    CAS  PubMed  Google Scholar 

  15. Andreassen TT, Fledelius C, Ejersted C, Oxlund H (2001) Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand 72: 304–307

    Article  CAS  PubMed  Google Scholar 

  16. Bollag G, Clapp D, Shih S, Adler F, Zhang Y, Thompson P, Lange B, Freedman M, McCormick F, Jacks T (1996) Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in hematopoietic cells. Nat Genet 12: 144–148

    Article  CAS  PubMed  Google Scholar 

  17. Stanislaus D, Yang X, Liang J, Wolfe J, Cain R, Onyia J, Falla N, Marder P, Bidwell J, Queener S, Hock J (2000) In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone, hPTH 1–34 fragment. Bone 27: 209–218

    CAS  PubMed  Google Scholar 

  18. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P (1999) Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14: 1167–1174

    CAS  PubMed  Google Scholar 

  19. Turner CH, Hsieh YF, Muller R, Bouxsein ML, Baylink DJ, Rosen CJ, Grynpas MD, Donahue LR, Beamer WG (2000) Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res 15: 1126–1131

    CAS  PubMed  Google Scholar 

  20. John V, Hock J, Short L, Glasebrook A, Galvin R (1996) A role for CD8+ T-lymphocytes in osteoclast differentiation in vitro. Endocrinology 137: 2457–2463

    Article  CAS  PubMed  Google Scholar 

  21. Onyia J, Miller B, Hulman J, Liang J, Galvin R, Frolik C, Chandrasekhar S, Harvey A, Bidwell J, Herring J, Hock J (1997) Proliferating cells in the primary spongiosa express the osteoblast phenotype in vitro. Bone 20: 93–100

    Article  CAS  PubMed  Google Scholar 

  22. Jerome C, Burr D, Bibber TV, Hock J, Brommage R (2001) Treatment with human parathryoid hormone (1–34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28: 150–159

    Article  CAS  PubMed  Google Scholar 

  23. Egan J, Gronowicz G, Rodan G (1991) Parathyroid hormone promotes the disassembly of cytoskeletal actin and myosin in cultured osteoblastic cells: mediation by cyclic AMP. J Cell Biochem 45: 101–111

    CAS  PubMed  Google Scholar 

  24. The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, Gusella JF, Hariharan IK, Bernards A (1997) Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 276: 791–794

    Article  CAS  PubMed  Google Scholar 

  25. Gutmann D, Wu YL, Hedrick NM, Zhu Y, Guha A, Parada LF (2001) Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet 10: 3009–3016

    CAS  PubMed  Google Scholar 

  26. Ingram DA, Hiatt K, King AJ, Fisher L, Shivakumar R, Derstine C, Wenning MJ, Diaz B, Travers JB, Hood A, Marshall M, Williams DA, Clapp DW (2001) Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 194: 57–69

    Article  CAS  PubMed  Google Scholar 

  27. Riccardi V (1992) Neurofibromatosis: phenotype, natural history and pathogenesis. Johns Hopkins University Press, Baltimore

    Google Scholar 

  28. Chen S, Ingram DA, Fisher L, Wenning MJ, Yu X, Hock JM, Clapp DW (2002) NF1 plays an essential role in osteoclasts development and its survival. Blood 100: 81

    Google Scholar 

  29. Aubin JE, Alders E, Heersche JN (1983) A primary role for microfilaments, but not microtubules, in hormone-induced cytoplasmic retraction. Exp Cell Res 143: 439–450

    Article  CAS  PubMed  Google Scholar 

  30. Chen C, Koh A, Zhang NDJ, Keller E, Xiao G, Franceschi R, D’Silva N, McCauley L (2004) Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem 279: 29121–29129

    CAS  PubMed  Google Scholar 

  31. Fujita T, Meguro T, Fukuyama R, Nakamuta H, Koida M (2002) New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. J Biol Chem 277: 22191–22200

    CAS  PubMed  Google Scholar 

  32. Miao D, Tong X, Chan G, Panda D, McPherson P, Goltzman D (2001) Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 276: 32204–32212

    Article  CAS  PubMed  Google Scholar 

  33. Swarthout JT, Doggett TA, Lemker JL, Partridge NC (2001) Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. J Biol Chem 276: 7586–7592

    Article  CAS  PubMed  Google Scholar 

  34. Li J, Duncan RL, Burr DB, Gattone VH, Turner CH (2003) Parathyroid hormone enhances mechanically induced bone formation, possibly involving L-type voltage-sensitive calcium channels. Endocrinology 144: 1226–1233

    CAS  PubMed  Google Scholar 

  35. You J, Reilly GC, Zhen X, Yellowley CE, Chen Q, Donahue HJ, Jacobs CR (2001) Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts. J Biol Chem 276: 13365–13371

    CAS  PubMed  Google Scholar 

  36. Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, Kucukceylan N, Abdel-Nour M, Gewies A, Peters H, Kaufmann D, Buske A, Tinschert S, Nurnberg P (2000) Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 66: 790–818

    Article  CAS  PubMed  Google Scholar 

  37. Kano J, Sugimoto T, Kanatani M, Kuroki Y, Tsukamoto T, Fukase M, Chihara K (1994) Second messenger signaling of c-fos gene induction by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: its role in osteoblast proliferation and osteoclast-like cell formation. J Cell Physiol 161: 358–366

    Article  CAS  PubMed  Google Scholar 

  38. Nishida S, Tsubaki M, Hoshino M, Namimatsu A, Uji H, Yoshioka S, Tanimori Y, Yanae M, Iwaki M, Irimajiri K (2005) Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2. Biochem Biophys Res Commun 328: 91–97

    Article  CAS  PubMed  Google Scholar 

  39. Theoleyre S, Wittrant Y, Couillaud S, Vusio P, Berreur M, Dunstan C, Blanchard F, Redini F, Heymann D (2004) Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK. Biochim Biophys Acta 1644: 1–7

    CAS  PubMed  Google Scholar 

  40. Onyia J, Miles R, Yang X, Halladay D, HAle J, Glasebrook A, McClure D, Seno G, Churgey L, Chandrasekhar S, Martin T (2000) In vivo demonstration that parathyroid hormone 1–38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. J Bone Miner Res 16: 863–871

    Google Scholar 

Download references

Acknowledgement

This work was funded by research grants to Drs. J. M. Hock and W. D. Clapp from The Neurofibromatosis Foundation and the U.S. Department of Defense Neurofibromatosis Research Program

Author information

Authors and Affiliations

  1. Department of Anatomy & Cell Biology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN, 46202, USA

    X. Yu, J. Milas, N. Watanabe, N. Rao, S. Murthy, O. L. Potter & J. M. Hock

  2. Department of Pediatrics, Indiana University School of Medicine, 1044 W. Walnut St., Indianapolis, IN, 46202, USA

    M. J. Wenning & W. D. Clapp

  3. Indiana University School of Dentistry, 1121 W. Michigan St., Indianapolis, IN, 46202, USA

    J. M. Hock

Authors
  1. X. Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Milas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Murthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. L. Potter
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. J. Wenning
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W. D. Clapp
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. M. Hock
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to X. Yu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, X., Milas, J., Watanabe, N. et al. Neurofibromatosis Type 1 Gene Haploinsufficiency Reduces AP-1 Gene Expression without Abrogating the Anabolic Effect of Parathyroid Hormone. Calcif Tissue Int 78, 162–170 (2006). https://doi.org/10.1007/s00223-005-0201-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-005-0201-x

Keywords

Search

Navigation